The pharmaceutical giant Johnson & Johnson allegedly failed to warn women that its vaginal mesh devices posed a particular risk for patients with compromised immune systems, despite it being “well known” before they were first sold in Australia. Johnson & Johnson withdraws pelvic mesh device from Australian market Read moreOver a six-month hearing, the federal court heard allegations that Johnson & Johnson either knew of the risks or failed to properly test the devices before launching them on the Australian market. On Monday, the women won the right to add a new allegation to its case: that Johnson & Johnson knew the devices posed an added risk for patients with compromised immune systems but failed to warn women. It was not until after Gill’s operation that warnings about immune problems were added to the instructions for a number of the mesh devices. The allegations about the immune system response were not initially included in the class action against Johnson & Johnson.

Source: The Guardian April 09, 2018 23:37 UTC